Implementation of Smoking Cessation Within NCI Community Oncology Research Program (NCORP) Sites

Study summary

Evaluate a multi-faceted training program to improve short-term smoking cessation rates (\<14 days post-visit) and short (3 months) and sustained abstinence (6 months) among 1,114 enrolled smokers who present for low-dose computed tomography (LDCT) lung cancer screening in 26 community-based practices.

Ask AI to explain this study

Start here

Key things to know

Main goalHealth Services Research

This describes the study’s primary purpose.

What is being studiedPersonnel Training and Coaching Calls

The study team can explain what participation involves.

Who it may be forSmoking Cessation

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jul 25, 2022 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?49 U.S. locations

Locations may change over time.

Who runs it?Wake Forest University Health Sciences

Study sponsor

Study overview

What this study is about

Purpose: Health Services Research
Study type: Interventional
Phase: Not applicable
Sponsor: Wake Forest University Health Sciences
Interventions being studied: Other: Personnel Training and Coaching Calls

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Agrees to have NCORP research personnel serve as the study liaison and another person to serve as the cessation program champion.
Agrees to participate in all aspects of the intervention, randomization, and evaluation.
Agrees to participate in a confidential 1-on-1 semi-structured interview with the research team.
Agrees to have the interview taped, transcribed and qualitatively analyzed.
Age ≥18 years
Potential participants will be screened using the following question: "Do you smoke cigarettes every day, some days, or not at all?" (BRFSS). A current smoker is anyone responds "every day" or "some days".

Reasons someone may not be able to joinExclusion criteria

Current use (previous 30 days) of a tobacco dependence treatment including bupropion, varenicline, and nicotine replacement
Individuals who use e-cigarettes and who are not smoking cigarettes. Dual users (those who use both e-cigarettes and cigarettes) will still be included in the trial.
The presence of a physical or cognitive impairment that would prevent a person from engaging in survey research (such as blindness, deafness, or dementia).
Individual has already completed the intended LDCT lung cancer screening for this study.
Non-English speaking participants.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Helen F Graham Cancer CenterNewark, Delaware
Augusta University Medical CenterAugusta, Georgia
Lewis Cancer and Research Pavilion at Saint Joseph's/CandlerSavannah, Georgia
Tripler Army Medical CenterHonolulu, Hawaii
Good Samaritan Regional Health CenterMount Vernon, Illinois
Carle Cancer CenterUrbana, Illinois
McFarland Clinic PC - AmesAmes, Iowa
Mercy Medical Center - Des MoinesDes Moines, Iowa
LSU Health Sciences Center at ShreveportShreveport, Louisiana
Saint Joseph Mercy HospitalAnn Arbor, Michigan
Spectrum Health at Butterworth CampusGrand Rapids, Michigan
William Beaumont Hospital-Royal OakRoyal Oak, Michigan

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 25, 2022. Always confirm current availability with the study team.

View original record ↗